Bruntwood SciTech has let the 41,000 sq ft Da Vinci Building at Melbourn Science Park, Cambridge, to Cellular Origins for the cell therapy company’s new global HQ.
Previously occupied by AstraZeneca, the building places the company at the heart of the UK’s R&D ‘Golden Triangle’.
The space will support the development and deployment of Cellular Origins’ automated manufacturing platform, Constellation, and the delivery of commercial-scale cell therapy manufacturing systems to customers. The move will also allow for significant expansion plans, including the doubling of its workforce.
Edwin Stone, CEO of Cellular Origins, said: “Securing the Da Vinci building as our new headquarters marks an important step in building Cellular Origins’ long term growth. Following a successful Series A raise in November 2025, this step allows us to create the right foundations, not just in technology, but in infrastructure, culture and capability to support our ambition to scale cell therapy manufacturing.
“As a spin-out from TTP, it’s particularly meaningful for us to continue our growth on Melbourn Science Park. This facility represents the kind of company we are building: one designed for scale, grounded in engineering excellence, and focused on delivering industrialised, scalable manufacturing. With Constellation, we are bringing a new, factory-led, fully-integrated automation approach to an industry that must scale to meet growing patient demand.”
Mark Leech, mergers and acquisitions director at Bruntwood SciTech – a joint venture between Bruntwood, L&G and Greater Manchester Pension Fund – added: “This landmark deal with Cellular Origins reflects our ambition for Melbourn Science Park – bringing together pioneering, innovation-led businesses with access to world-leading research and talent to help them scale in the UK. Having worked closely with the team throughout this process, we’re excited by the pace of their growth, the scale of their plans and their confidence in the park to support their next phase.
“Melbourn Science Park has a strong track record of supporting some of the most exciting science and technology businesses. Its combination of high quality facilities and a collaborative, wellbeing-focused environment – alongside access to Bruntwood SciTech’s UK-wide ecosystem of partners, talent and innovation-led companies – creates the conditions for businesses and their people to grow and thrive, particularly in high-growth areas such as advanced therapies and life sciences.”
